CA2321406A1 - Restauration de la fonction de barriere perturbee par application d'anti-androgenes - Google Patents

Restauration de la fonction de barriere perturbee par application d'anti-androgenes Download PDF

Info

Publication number
CA2321406A1
CA2321406A1 CA002321406A CA2321406A CA2321406A1 CA 2321406 A1 CA2321406 A1 CA 2321406A1 CA 002321406 A CA002321406 A CA 002321406A CA 2321406 A CA2321406 A CA 2321406A CA 2321406 A1 CA2321406 A1 CA 2321406A1
Authority
CA
Canada
Prior art keywords
antiandrogen
testosterone
accordance
barrier
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002321406A
Other languages
English (en)
Inventor
Peter M. Elias
Kenneth R. Feingold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
US Department of Veterans Affairs VA
Original Assignee
University of California
US Department of Veterans Affairs VA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, US Department of Veterans Affairs VA filed Critical University of California
Priority to CA002321406A priority Critical patent/CA2321406A1/fr
Priority to AU2002213433A priority patent/AU2002213433A1/en
Priority to PCT/US2001/042403 priority patent/WO2002026325A2/fr
Publication of CA2321406A1 publication Critical patent/CA2321406A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002321406A 2000-09-29 2000-09-29 Restauration de la fonction de barriere perturbee par application d'anti-androgenes Abandoned CA2321406A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002321406A CA2321406A1 (fr) 2000-09-29 2000-09-29 Restauration de la fonction de barriere perturbee par application d'anti-androgenes
AU2002213433A AU2002213433A1 (en) 2000-09-29 2001-09-27 Restoration of perturbed barrier function by application of antiandrogens
PCT/US2001/042403 WO2002026325A2 (fr) 2000-09-29 2001-09-27 Restauration de la fonction barriere par application d'antiandrogenes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67615500A 2000-09-29 2000-09-29
CA002321406A CA2321406A1 (fr) 2000-09-29 2000-09-29 Restauration de la fonction de barriere perturbee par application d'anti-androgenes

Publications (1)

Publication Number Publication Date
CA2321406A1 true CA2321406A1 (fr) 2002-03-29

Family

ID=25682128

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002321406A Abandoned CA2321406A1 (fr) 2000-09-29 2000-09-29 Restauration de la fonction de barriere perturbee par application d'anti-androgenes

Country Status (3)

Country Link
AU (1) AU2002213433A1 (fr)
CA (1) CA2321406A1 (fr)
WO (1) WO2002026325A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9078888B2 (en) 2007-01-22 2015-07-14 Gtx, Inc. Nuclear receptor binding agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
IL124764A0 (en) * 1998-06-04 1999-01-26 Univ Ben Gurion Topical composition for treatment of baldness

Also Published As

Publication number Publication date
AU2002213433A1 (en) 2002-04-08
WO2002026325A2 (fr) 2002-04-04
WO2002026325A9 (fr) 2003-02-13
WO2002026325A3 (fr) 2002-08-22

Similar Documents

Publication Publication Date Title
Kanikkannan et al. Structure-activity relationship of chemical penetration enhan-cers in transdermal drug delivery
El Maghraby et al. Liposomes and skin: from drug delivery to model membranes
EP0299756B1 (fr) Composition anti-acneique
JP3611657B2 (ja) 乳酸デヒドロゲナーゼ阻害剤を含む化粧品組成物
US5728733A (en) N-acyl-ethylene triacetic composition for treating abnormal keratinization
US20070140999A1 (en) Topical skin care composition containing refined peanut oil
CA2760186A1 (fr) Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
JP2014508796A (ja) 脂質ナノ粒子とコルチコステロイドまたはビタミンｄ誘導体とを含む組成物
JP2001510487A (ja) 遊離スフィンゴイド塩基及びセラミドの組合せを含む組成物並びにその使用
Bergler-Czop et al. Dermatological problems of the puberty
JP2950789B2 (ja) ２−アミノ−１，３−アルカンジオールを含有する、髪抜け遅延および／または髪成長誘発および刺激剤
KR100864129B1 (ko) 여드름 치료를 위한 국소 답손
JP2003508486A (ja) 皮膚脂質含量の改良のための組成物及び方法
AU2009246330B2 (en) Prostaglandin based compositions and method of use thereof
CA2321406A1 (fr) Restauration de la fonction de barriere perturbee par application d'anti-androgenes
Skaare et al. The influence of triclosan, zinc or propylene glycol on oral mucosa exposed to sodium lauryl sulphate
WO2006122668A1 (fr) Combinaisons de matieres actives formees de glycerides de glucosyle et de creatine et/ou de creatinine
WO1998048775A1 (fr) Serine protease et compositions retinoides topiques
US4272508A (en) Cosmetics for treatment of hair and skin
KR20220044739A (ko) 국소 조성물
KR100570847B1 (ko) 여드름 피부용 조성물
US6982284B1 (en) Compositions and methods for modification of skin lipid content
JP2002128702A (ja) 局所活性成分の効力のモノ−アシル−（リゾ）−グリセロリン脂質による増強方法およびその用途
US20040022780A1 (en) Serine protease and topical retinoid compositions useful for treatment of acne vulgarise and production of anti-aging effects
DE60018438T2 (de) Pharmazeutische und/oder kosmetische zusammensetzungen

Legal Events

Date Code Title Description
FZDE Dead